Atlas Trials

Human Papillomavirus-Related Carcinoma

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Papillomavirus-Related Carcinoma

RecordFirmDate
A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer (NCT05232851)Mayo Clinic2022-06-16
Human Papillomavirus Education Programs (NCT04880837)Ohio State University Comprehensive Cancer Center2022-04-27
HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer (NCT04580446)University of Texas Southwestern Medical Center2020-12-03
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults (NCT04474821)Mayo Clinic2020-10-19
Molecular Signatures of HPV+ ORL Cancers (OROPAP) (NCT04189003)Assistance Publique - Hôpitaux de Paris2019-06-01
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer (NCT03634267)M.D. Anderson Cancer Center2018-08-03
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients (NCT03036930)National Cancer Institute (NCI)2017-06-23
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants (NCT02568566)National Cancer Institute (NCI)2016-05-19
HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA (NCT02379520)Baylor College of Medicine2015-09-01
Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening (NCT04927650)University of California, San Francisco2015-01-08
Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients (NCT02624349)The Hospital for Sick Children2013-10-01
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making (NCT01769560)University of Michigan2013-01-01

Track Human Papillomavirus-Related Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.